NCT01834586View on ClinicalTrials.gov

Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Multiple Sclerosis
Interventions
DRUG

Anesthetic Topical Adhesive Synera

"For subjects taking interferon beta subcutaneous (Betaseron, Extavia or Rebif) apply one patch 60 minutes prior to each injection (every-other day or three times per week) for two weeks, then 30 minutes prior for two weeks.~For subjects taking glatiramer acetate subcutaneous (Copaxone) apply one patch 60 minutes prior to each injection (daily) for one week and then 30 minutes prior for one week"

Trial Locations (1)

98034

MS Center at Evergreen Health, Kirkland

All Listed Sponsors
lead

Brown, Theodore R., M.D., MPH

INDIV

NCT01834586 - Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications | Biotech Hunter | Biotech Hunter